Pharmacology
Conference Coverage
Traditional Chinese medicine improves outcomes in HFrEF
The ESC-invited discussant called the outcome “remarkable” and a validation for “the millions of people” who are already taking qiliqiangxin in...
Conference Coverage
No reduction in AFib after noncardiac surgery with colchicine: COP-AF
“We think that further studies are needed to tease out which patients can benefit from colchicine and in what setting it can be used.”
Conference Coverage
ESC backs SGLT2 inhibitor plus GLP-1 in diabetes with high CVD risk
Another major change in the new ESC guideline revision is introduction of a CVD risk calculator intended to estimate the risk among people with...
News
Liraglutide fixes learning limit tied to insulin resistance
The normalization in associative learning that one dose of liraglutide produced in people with obesity “fits with studies showing that these drugs...
Conference Coverage
Wegovy scores HFpEF benefits in people with obesity
The results “indicate that treatment with semaglutide is a valuable therapeutic approach in the management of patients with HFpEF and obesity.”
News
FDA okays first biosimilar for multiple sclerosis
“Biosimilar medications offer additional effective treatment options that have the potential to increase access for people living with relapsing...
Latest News
Breast cancer: Hope in sight for improved tamoxifen therapy?
Eventually, the idea is to combine treatment with antiestrogens with a medicinal product that promotes localization of PRMT5 in the nucleus to...
News
New recommendation expands antiretroviral guidance for HIV
The task force is backing all three treatment regimens and is recommending that clinicians use whichever formulation is most appropriate for their...
News
New RSV shot is a monoclonal antibody, not a vaccine
Monoclonal antibodies are often used for treatment rather than prevention.
Conference Coverage
Expert calls for sparing oxygen use for dyspnea in the emergency department
Oxygen therapy is used too often in patients with respiratory difficulties, says one expert.